Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through studyMarc Ferrante, Luciana Teixeira de Campos, Minhu Chen et al.|The Lancet|2024Cited by 107
Prevalence of low protein intake in 80+ year-old community-dwelling adults and association with dietary patterns and modifiable risk factors- <i>A cross-sectional study</i>Sussi Friis Buhl, Anne Marie Beck, Britt Christensen et al.|University of Southern Denmark Research Portal (University of Southern Denmark)|2022Cited by 11